Anders Jacobson
Director/Board Member en KLARIA PHARMA HOLDING AB .
Fortuna: 6 378 $ al 31/03/2024
Perfil
Anders Jacobson is currently the Deputy Chairman at MD Biomedical AB.
He is also an Independent Director at Klaria Pharma Holding AB and the Chief Innovation Officer at Senzime AB.
Previously, he served as a Director at Acarix AB from 2020 to 2021.
Mr. Jacobson holds a graduate degree from the University of Uppsala.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SENZIME AB
0.01% | 30/12/2022 | 11 000 ( 0.01% ) | 6 378 $ | 31/03/2024 |
Cargos activos de Anders Jacobson
| Empresas | Cargo | Inicio |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01/02/2022 |
| KLARIA PHARMA HOLDING AB | Director/Board Member | 01/01/2022 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The private company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Director/Board Member | - |
Antiguos cargos conocidos de Anders Jacobson.
| Empresas | Cargo | Fin |
|---|---|---|
| ACARIX AB | Director/Board Member | 11/05/2021 |
Formación de Anders Jacobson.
| University of Uppsala | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| SENZIME AB | Health Technology |
| ACARIX AB | Health Technology |
| KLARIA PHARMA HOLDING AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The private company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
- Bolsa de valores
- Insiders
- Anders Jacobson
